Acute dronedarone is inferior to amiodarone in terminating and preventing atrial fibrillation in canine atria

Heart Rhythm

Volumn 7, Issue 9, 2010, Pages 1273-1279

  Burashnikov, Alexander ^a   Belardinelli, Luiz ^b   Antzelevitch, Charles ^a  

^a MASONIC MEDICAL RESEARCH LABORATORY   (United States)

^b Gilead Sciences   (United States)

Author keywords

Amiodarone; Antiarrhythmic agents; Atrial fibrillation; Dronedarone

Indexed keywords

ACETYLCHOLINE; AMIODARONE; DRONEDARONE;

ACTION POTENTIAL DURATION; ACUTE DRUG ADMINISTRATION; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARDIOVASCULAR PARAMETERS; DIASTOLIC THRESHOLD OF EXCITATION; DOG; DRUG EFFECT; ELECTROCARDIOGRAPHY; HEART ATRIUM; HEART ATRIUM FIBRILLATION; HEART MUSCLE FIBER MEMBRANE POTENTIAL; HEART MUSCLE REFRACTORY PERIOD; ISOLATED HEART; NONHUMAN; PRIORITY JOURNAL;

AMIODARONE; ANIMALS; ANTI-ARRHYTHMIA AGENTS; ATRIAL FIBRILLATION; DISEASE MODELS, ANIMAL; DOGS; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTROPHYSIOLOGIC TECHNIQUES, CARDIAC; HEART ATRIA; HEART CONDUCTION SYSTEM; TREATMENT OUTCOME;

EID: 77956192639     PISSN: 15475271     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.hrthm.2010.05.019     Document Type: Article

References (36)

1. E.N. Prystowsky Atrial fibrillation: dronedarone and amiodaronethe safety versus efficacy debate Nat Rev Cardiol 7 2010 5 6
2. A. Burashnikov, and C. Antzelevitch New development in atrial antiarrhythmic drug therapy Nat Rev Cardiol 7 2010 139 148
3. J.P. Piccini, V. Hasselblad, and E.D. Peterson Comparative efficacy of dronedarone and amiodarone for the maintenance of sinus rhythm in patients with atrial fibrillation J Am Coll Cardiol 54 2009 1089 1095
4. P. Barquet DIONYSOS study results showed the respective profile of dronedarone and amiodarone en.sanofi-aventis.com/binaries/20081223-dionysos-fe- en-en-tcm28-23624.pdf 2008 Accessed March 21, 2010
5. P. Touboul, J. Brugada, and A. Capucci Dronedarone for prevention of atrial fibrillation: a dose-ranging study Eur Heart J 24 2003 1481 1487
6. B.N. Singh, S.J. Connolly, and H.J. Crijns Dronedarone for maintenance of sinus rhythm in atrial fibrillation or flutter N Engl J Med 357 2007 987 999
7. A. Burashnikov, J.M. Di Diego, and A.C. Zygmunt Atrium-selective sodium channel block as a strategy for suppression of atrial fibrillation: differences in sodium channel inactivation between atria and ventricles and the role of ranolazine Circulation 116 2007 1449 1457
8. F. Bode, M. Kilborn, and P. Karasik The repolarization-excitability relationship in the human right atrium is unaffected by cycle length, recording site and prior arrhythmias J Am Coll Cardiol 37 2001 920 925
9. A. Burashnikov, and C. Antzelevitch Reinduction of atrial fibrillation immediately after termination of the arrhythmia is mediated by late phase 3 early afterdepolarization-induced triggered activity Circulation 107 2003 2355 2360
10. A. Burashnikov, J.M. Di Diego, and S. Sicouri Atrial-selective effects of chronic amiodarone in the management of atrial fibrillation Heart Rhythm 5 2008 1735 1742
11. Kur block Am J Physiol 286 2004 H2393 H2400
12. A. Varro, J. Takacs, and M. Nemeth Electrophysiological effects of dronedarone (SR 33589), a noniodinated amiodarone derivative in the canine heart: comparison with amiodarone Br J Pharmacol 133 2001 625 634
13. P. Gautier, E. Guillemare, and A. Marion Electrophysiologic characterization of dronedarone in guinea pig ventricular cells J Cardiovasc Pharmacol 41 2003 191 202
14. W. Sun, J.S. Sarma, and B.N. Singh Electrophysiological effects of dronedarone (SR33589), a noniodinated benzofuran derivative, in the rabbit heart: comparison with amiodarone Circulation 100 1999 2276 2281
15. S. Moro, M. Ferreiro, and D. Celestino In vitro effects of acute amiodarone and dronedarone on epicardial, endocardial, and M cells of the canine ventricle J Cardiovasc Pharmacol Ther 12 2007 314 321
16. W. Sun, J.S. Sarma, and B.N. Singh Chronic and acute effects of dronedarone on the action potential of rabbit atrial muscle preparations: comparison with amiodarone J Cardiovasc Pharmacol 39 2002 677 684
17. A. Manning, V. Thisse, and D. Hodeige SR 33589, a new amiodarone-like antiarrhythmic agent: electrophysiological effects in anesthetized dogs J Cardiovasc Pharmacol 25 1995 252 261
18. M.V. Elizari, R.J. Levi, and A. Novakosky Cellular effects of antiarrhythymic drugs Remarks on methodology VIII European Congress of Cardiology 1980 11
19. P. Kirchhof, H. Degen, and M.R. Franz Amiodarone-induced postrepolarization refractoriness suppresses induction of ventricular fibrillation J Pharmacol Exp Ther 305 2003 257 263
20. C. Patel, G.X. Yan, and P.R. Kowey Dronedarone Circulation 120 2009 636 644
21. N. Lalevee, J. Nargeot, and S. Barrere-Lemaire Effects of amiodarone and dronedarone on voltage-dependent sodium current in human cardiomyocytes J Cardiovasc Electrophysiol 14 2003 885 890
22. E. Guillemare, A. Marion, and D. Nisato Inhibitory effects of dronedarone on muscarinic K+ current in guinea pig atrial cells J Cardiovasc Pharmacol 36 2000 802 805
23. V. Fuster, L.E. Ryden, and D.S. Cannom ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillationexecutive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation) J Am Coll Cardiol 48 2006 854 906
24. O. Finance, J. Planchenault, and S. Bethegnies Electrophysiological and anti-arrhythmic actions of a new amiodarone-like agent, dronedarone in experimental atrial fibrillation (abstract) J Mol Cell Cardiol 30 1998 A251
25. S. Cosnier-Pucheu, P. Guiraudou, and G. Rizzoli Effects of amiodarone and dronedarone in the prevention of atrial arrhythmias in guinea pig isolated heart (abstract) Arch Mal Coeur Vaiss 94 2001 21
26. L. Kober, C. Torp-Pedersen, and J.J. McMurray Increased mortality after dronedarone therapy for severe heart failure N Engl J Med 358 2008 2678 2687
27. G.H. Bardy, K.L. Lee, and D.B. Mark Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure N Engl J Med 352 2005 225 237
28. S.H. Hohnloser, H.J. Crijns, and E.M. van Effect of dronedarone on cardiovascular events in atrial fibrillation N Engl J Med 360 2009 668 678
29. S.J. Connolly, H.J. Crijns, and C. Torp-Pedersen Analysis of stroke in ATHENA: a placebo-controlled, double-blind, parallel-arm trial to assess the efficacy of dronedarone 400 mg BID for the prevention of cardiovascular hospitalization or death from any cause in patients with atrial fibrillation/atrial flutter Circulation 120 2009 1174 1180
30. P. Kirchhof, J. Bax, and C. Blomstrom-Lundquist Early and comprehensive management of atrial fibrillation: proceedings from the 2nd AFNET/EHRA consensus conference on atrial fibrillation entitled "research perspectives in atrial fibrillation" Europace 11 2009 860 885
31. R.H. Falk, and A.J. Camm Rethinking the reasons to treat atrial fibrillation? The role of dronedarone in reducing cardiovascular hospitalizations Eur Heart J 30 2009 2438 2440
32. O.D. Pedersen, H. Bagger, and N. Keller Efficacy of dofetilide in the treatment of atrial fibrillation-flutter in patients with reduced left ventricular function: a Danish investigations of arrhythmia and mortality on dofetilide (DIAMOND) substudy Circulation 104 2001 292 296
33. D.G. Julian, A.J. Camm, and G. Frangin Randomised trial of effect of amiodarone on mortality in patients with left-ventricular dysfunction after recent myocardial infarction: EMIAT European Myocardial Infarct Amiodarone Trial Investigators Lancet 349 1997 667 674
34. J.A. Cairns, S.J. Connolly, and R. Roberts Randomised trial of outcome after myocardial infarction in patients with frequent or repetitive ventricular premature depolarisations: CAMIAT Canadian Amiodarone Myocardial Infarction Arrhythmia Trial Investigators Lancet 349 1997 675 682
35. C. Lafuente-Lafuente, S. Mouly, and M.A. Longas-Tejero Antiarrhythmics for maintaining sinus rhythm after cardioversion of atrial fibrillation Cochrane Database Syst Rev 4 2007 CD005049
36. C. Torp-Pedersen, M. Moller, and P.E. Bloch-Thomsen Dofetilide in patients with congestive heart failure and left ventricular dysfunction Danish Investigations of Arrhythmia and Mortality on Dofetilide Study Group N Engl J Med 341 1999 857 865